PAPPA2 and preeclampsia: They were described as markers of placental abnormality (e.g., INHBA, ADAM12, PGF), preeclampsia risk (e.g., PAPPA2, KISS1, CLIC3), and placental hypoxia (e.g., ANGPTL4).